| PERIOD ENDING | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | | Total Revenue | 1,535,000 | 1,573,000 | 1,466,000 | 1,610,000 | | Cost of Revenue | 592,000 | 110,000 | 1,099,000 | 2,515,000 | | | Gross Profit | 943,000 | 1,463,000 | 367,000 | (905,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 629,000 | 1,182,000 | 134,000 | (1,232,000) | | Non Recurring | 22,000 | 1,000 | 9,000 | 5,000 | | Others | 83,000 | 81,000 | 78,000 | 80,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 209,000 | 199,000 | 146,000 | 242,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,000) | 4,000 | (1,000) | (15,000) | | Earnings Before Interest And Taxes | 197,000 | 208,000 | 151,000 | 239,000 | | Interest Expense | 45,000 | 58,000 | 47,000 | 48,000 | | Income Before Tax | 152,000 | 150,000 | 104,000 | 191,000 | | Income Tax Expense | 38,000 | 42,000 | 26,000 | 44,000 | | Minority Interest | (1,000) | (1,000) | 1,000 | (1,000) | | | | Net Income From Continuing Ops | 113,000 | 107,000 | 79,000 | 146,000 | | | Non-recurring Events | | Discontinued Operations |
-
| (2,000) | (47,000) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 113,000 | 105,000 | 32,000 | 146,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $113,000 | $105,000 | $32,000 | $146,000 |
|
3.31% Nasdaq 
Income Statement
